期刊文献+

不同透析方式治疗尿毒症患者的临床疗效分析

Clinical Effect Analysis of Different Methods of Dialysis in Treating Uremic Patients
下载PDF
导出
摘要 目的 探讨不同透析方式治疗尿毒症患者的临床疗效。方法整群选择2013年5月—2015年5月期间该院收治的114例尿毒症患者作为研究对象,根据随机数字表将其平均分为HD组、HD+HP组与HDF组,每组38例。结果3组治疗后Scr、Pi、BUN均较治疗前明显降低,但3组间对比差异均无统计学意义(P>0.05)。经相应治疗后,HD+HP组与HDF组β2-MG、PTH及Cys C参数均低于HD组(P<0.05);HD+HP组与HDF组β2-MG、PTH及Cys C参数对比差异无统计学意义(P>0.05)。结论 HD、HDF与HD+HP对于小分子物质的清除效果基本相同,而HDF与HD+HP对中、大分子物质的清除作用却优于单纯HD,可作为尿毒症首选治疗方案,适于临床推广。 Objective To investigate the clinical effect of different methods of dialysis in treating uremic patients. Methods114 cases with uraemia admitted in our hospital from May 2013 to May 2015 were selected as the subjects and randomly divided into HD group(hematodialysis), HD+HP group(hematodialysis and hemoperfusion) and HDF group(hematodialysis and hemofiltration), 38 cases in each group. Results Scr, Pi and BUN all obviously reduced after treatment. The difference in Scr, Pi and BUN between three groups had no statistical significance(P〈0.05). After treatment, the β2-MG, PTH and Cys C in HD+HP group and HDF group were lower than in HD group(P〈0.05). The difference in β2-MG, PTH and Cys C between HD+HP group and HDF group had no statistical significance(P0.05). Conclusion HD, HDF and HD+HP have essentially the same effect on clearing small molecule material. The effect of HDF and HD+HP on clearing the medium and macromolecule material was obviously better than HD, so it can be used as the first therapy for uraemia and is suitable for clinical promotion.
作者 裴文燕
出处 《中外医疗》 2016年第7期18-20,共3页 China & Foreign Medical Treatment
关键词 血液灌流 血液透析 尿毒症 临床疗效 Hemoperfusion Hemodialysis Uremia Clinical effect
  • 相关文献

参考文献8

二级参考文献61

  • 1叶朝阳.高通量血液透析的临床应用体会[J].肾脏病与透析肾移植杂志,2005,14(3):251-252. 被引量:32
  • 2郑宏,高洁.不同血液净化方法治疗尿毒症患者皮肤瘙痒[J].临床军医杂志,2010,38(6):1037-1039. 被引量:16
  • 3吴华.维持性透析患者心血管并发症的防治策略[J].中华肾脏病杂志,2006,22(3):140-142. 被引量:15
  • 4程晓媚,谢金芝,聂燕.血液灌流联合血液透析治疗尿毒症皮肤瘙痒的临床观察[J].现代中西医结合杂志,2006,15(20):2779-2780. 被引量:22
  • 5叶任高.内科学[M].5版.北京:人民卫生出版社,2009:826.
  • 6李惠群.陈世件.叶任高.腹膜透析治疗慢性肾衰存活期、生存率及死冈分析[J].中华肾脏病杂志,2007,10(12):287-288.
  • 7叶任高,岳少妲.肾功能衰竭与腹膜透析疗法[M].济南:山东科学技术出版社.2008:259-260.
  • 8叶任高,崔惠敏,李惠群."0"型管进行腹膜透析的优越性初步报告[J].中华肾脏病杂志,2009,19(14):244-245.
  • 9J. Bellien,C. Freguin,F. Le Roy,I. Remy-Jouet,M. Hanoy,C. Monteil,C. Thuillez,M. Godin,R. Joannides.Comparison of high-efficiency on-line hemodiafiltration and high-flux hemodialysis on vascular function and structure in end-stage renal disease patients[J]. Artery Research . 2012 (4)
  • 10Noriyuki Ouchi,Shinji Kihara,Yukio Arita,Makoto Nishida,Akifumi Matsuyama,Yoshihisa Okamoto,Masato Ishigami,Hiroshi Kuriyama,Ken Kishida,Hitoshi Nishizawa,Kikuko Hotta,Masahiro Muraguchi,Yasukazu Ohmoto,Shizuya Yamashita,Tohru Funahashi,Yuji Matsuzawa.Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages[J]. Circulation: Journal of the American Heart Association . 2001 (8)

共引文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部